International practice survey on palliative lung radiotherapy: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control

Clinical Lung Cancer

Volumn 13, Issue 3, 2012, Pages 225-235

  Rodrigues, George ^a   Macbeth, Fergus ^b   Burmeister, Bryan ^c   Kelly, Karie Lynn ^d   Bezjak, Andrea ^e   Langer, Corey ^f   Hahn, Carol ^g   Vichare, Anushree ^h   Movsas, Benjamin ⁱ  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d Kootenai Cancer Center   (United States)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h American Society for Radiation Oncology (ASTRO)   (United States)

ⁱ HENRY FORD HOSPITAL   (United States)

Author keywords

Concurrent chemotherapy; Endobronchial brachytherapy; External beam radiation therapy; Lung cancer; Practice survey

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CONSENSUS; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG CANCER; PROGNOSIS; RADIATION DOSE FRACTIONATION; SYMPTOM;

BRACHYTHERAPY; CHEMORADIOTHERAPY, ADJUVANT; EVIDENCE-BASED MEDICINE; HUMANS; INTERNATIONAL COOPERATION; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; PALLIATIVE CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; PROCESS ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; RISK ASSESSMENT; UNITED STATES;

EID: 84859865303     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.11.002     Document Type: Article

References (53)

1. Raby B, Pater J, Mackillop WJ. Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. J Clin Oncol 1995; 13:1904-11.
2. Falk SJ, Girling DJ, White RJ, et al. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. BMJ 2002; 325:465.
3. Simpson JR, Francis ME, Perez-Tamayo R, et al. Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 1985; 11:751-8. (Pubitemid 15086898)
4. Teo P, Tai TH, Choy D, et al. A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1988; 14:867-71.
5. Medical Research Council Lung Cancer Working Party. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 1991; 63:265-70.
6. Medical Research Council Lung Cancer Working Party. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer (NSCLC) and poor performance status. Br J Cancer 1992; 65:934-41.
7. Abratt RP, Shepherd LJ, Mameena Salton DG. Palliative radiation for stage 3 non-small cell lung cancer-a prospective study of two moderately high dose regimens. Lung Cancer 1995; 13:137-43.
8. Medical Research Council Lung Cancer Working Party. Randomized trial of palliative two-fraction versus more intensive thirteen fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clin Oncol 1996; 8:167-75.
9. Rees GJ, Devrell CE, Barley VL, et al. Palliative radiotherapy for lung cancer; two versus five fractions. Clin Oncol 1997; 9:90-5. (Pubitemid 27198976)
10. Reinfuss M, Glinski B, Kowalska T, et al. Radiotherapy in stage III, unresectable, asymptomatic non-small cell lung cancer. Final results of a prospective randomized study of 240 patients. Cancer Radiother 1999; 3:475-9.
11. Nestle U, Nieder N, Walter K, et al. A palliative accelerated irradiation regimen for advanced non-small cell lung cancer vs. conventionally fractionated 60 Gy: results of a randomized equivalence study. Int J Radiat Oncol Biol Phys 2000; 48:95-103. (Pubitemid 30488218)
12. Bezjak A, Dixon P, Brundage M, et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). Int J Radiat Oncol Biol Phys 2002; 54:719-28.
13. Sundstrom S, Bremnes R, Aasebo U, et al. Hypofractionated palliative radiotherapy (17 Gy per 2 fractions) in advanced non-small cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol 2004; 22:801-10. (Pubitemid 41103591)
14. Erridge SC, Gaze MN, Price A, et al. Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol 2005; 17:61-7. (Pubitemid 40090198)
15. Kramer GW, Wanders SL, Noordijk EM, et al. Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small cell lung cancer. J Clin Oncol 2005; 23:2962-70. (Pubitemid 46224115)
16. Senkus-Konefka E, Dziadziuszko R, Bednaruk-Mlynski E, et al. A prospective randomised study to compare two palliative radiotherapy schedules for non-small cell lung cancer (NSCLC). Br J Cancer 2005; 92:1038-45. (Pubitemid 40546666)
17. Mallick I, Sharma SC, Behera D, et al. Optimization of dose and fractionation of endobronchial brachytherapy with or without external radiation in palliative management of non-small cell lung cancer: a prospective randomized study. J Can Res Ther 2006; 2:119-25. (Pubitemid 44477532)
18. Sur R, Ahmed SN, Donde B, et al. Brachytherapy boost vs. teletherapy boost in palliation of symptomatic, locally advanced non-small cell lung cancer: preliminary analysis of a randomized, prospective study. J Brachyther Int 2001; 17:309-15. (Pubitemid 34225576)
19. Sur R, Donde B, Mohuiddin M, et al. Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non-small cell lung cancer (NSCLC) treated with radiation alone. Int J Radiat Oncol Biol Phys 2004; 60:S205.
20. Langendijk H, de Jong J, Tjwa M, et al. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol 2001; 58:257-68. (Pubitemid 32181859)
21. Chella A, Ambrogi MC, Ribechini A, et al. Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study. Lung Cancer 2000; 27:169-75. (Pubitemid 30105656)
22. Stout R, Barber P, Burt P, et al. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiother Oncol 2000; 56:323-7.
23. Huber RM, Fischer R, Hautmann H, et al. Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules. Chest 1995; 107:463-70.
24. Ball D, Smith J, Bishop J, et al. A phase III study of radiotherapy with and without continuous infusion fluorouracil as palliation for non-small cell lung cancer. Br J Cancer 1997; 75:690-7. (Pubitemid 27091083)
25. Burmeister BH, Fielding DI, Ramsay JR, et al. A phase I study of moderate-dose radiation therapy and weekly gemcitabine in patients with locally advanced nonsmall cell lung cancer not suitable for radical curative chemoradiation therapy. Clin Oncol 2005; 17:332-6. (Pubitemid 40932105)
26. Choi B, Robins HI, Schiller J, et al. A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer. Cancer Chemother Pharmacol 2008; 63:175-9.
27. Jeremic B, Shibamoto Y, Milicic B, et al. Short-term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer: a phase II study. Lung Cancer 1999; 24:1-9. (Pubitemid 29241811)
28. Michael M, Wirth A, Ball DL, et al. A phase I trial of high-dose palliative radiotherapy plus concurrent weekly vinorelbine and cisplatin in patients with locally advanced and metastatic NSCLC. Br J Cancer 2005; 93:652-61. (Pubitemid 41486456)
29. Ng QS, Goh V, Carnell D, et al. Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2007; 67:1375-80. (Pubitemid 46467170)
30. Schwarzenberger P, Theodossiou C, Barron S, et al. Dose escalation of docetaxel concomitant with hypofractionated, once weekly chest radiotherapy for non-small cell lung cancer: a phase I study. Am J Clin Oncol 2004; 27:395-9. (Pubitemid 39045251)
31. Seiwert TY, Connell PP, Mauer AM, et al. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer. Clin Cancer Res 2007; 13(2 Pt 1):515-22. (Pubitemid 46225357)
32. Scottish Intercollegiate Guidelines Network: Management of patients with lung cancer: a national clinical guideline. Available at: http://www.sign.ac.uk/ pdf/sign80.pdf. Accessed: July 13, 2010.
33. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997; 15:2996-3018.
34. Graham MV, Byhardt RW, Sause WT, et al. Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215(suppl):1347-62.
35. Lester JF, Macbeth FR, Toy E, et al. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 2006; 4:CD002143.
36. National Comprehensive Cancer Network: Treatment guidelines - NCCN Clinical Practice Guidelines in Oncology Non-Small Cell Lung Cancer V.1, 2011. Available at: http://www.nccn.org/professionals/physician-gls/PDF/nscl.pdf. Accessed: November 1, 2010.
37. Okawara G, Mackay JA, Evans WK, et al. Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Management of unresected stage III non-small cell lung cancer: a systematic review. J Thorac Oncol 2006; 1:377-93.
38. Ung YC, Yu E, Falkson C, et al. The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small cell lung cancer: a systematic review. Brachytherapy 2006; 5:189-202. (Pubitemid 44088682)
39. Cardona AF, Reveiz L, Ospina EG, et al. Palliative endobronchial brachytherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2008; 2:CD004284.
40. Timothy AR, Girling DJ, Saunders MI, et al Second Workshop on Palliative Radiotherapy and Symptom Control. Radiotherapy for inoperable lung cancer. Clin Oncol (R Coll Radiol) 2001; 13:86-7.
41. Brundage MD, Bezjak A, Dixon P, et al. The role of palliative thoracic radiotherapy in non-small cell lung cancer. Can J Oncol 1996; 6(suppl 1):25-32.
42. Macbeth FR, Abratt RP, Cho KH, et al International Atomic Energy Agency. Lung cancer management in limited resource settings: Guidelines for appropriate good care. Radiother Oncol 2007; 82:123-31. (Pubitemid 46275136)
43. Fairchild A, Harris K, Barnes E, et al. Palliative thoracic radiotherapy for lung cancer: A systematic review. J Clin Oncol 2008; 26:4001-11.
44. Kepka L, Olszyna-Serementa M. Palliative thoracic radiotherapy for lung cancer. Expert Rev Anticancer Ther 2010; 10:559-69.
45. Macbeth F, Stephens R. Palliative treatment for advanced non-small cell lung cancer. Hematol Oncol Clin North Am 2004; 18:115-30. (Pubitemid 38201553)
46. British Columbia Cancer Agency Cancer Management Guidelines: Non-Small Cell Lung Cancer. Available at: http://www.bccancer.bc.ca/HPI/ CancerManagementGuidelines/Lung/6ManagementPolicies/641NonSmallCellLungCancer/ 13Palliative RadiotherapyforLocallyAdvancedandMetastaticNSCLS.htm. Assessed November 1, 2010.
47. Tjan-Heijnen VC, Groen HJ, Schramel FM, Stoter G; Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung diseases and Tuberculosis. Consensus conference on palliative treatment of stage IV non-small cell lung cancer. Consensus meeting of the Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung Diseases and Tuberculosis. Neth J Med 2001; 58:52-61. (Pubitemid 32106925)
48. Han K, Bezjak A, Xu W, et al. Has the practice of radiation oncology for locally advanced and metastatic non-small cell lung cancer changed in Canada? Curr Oncol 2010; 17:33-40.
49. Fairchild A, Goh P, Sinclair E, et al. Has the pattern of practice in the prescription of radiotherapy for the palliation of thoracic symptoms changed between 1999 and 2006 at the rapid response radiotherapy program? Int J Radiat Oncol Biol Phys 2008; 70:693-700. (Pubitemid 351199731)
50. van den Hout WB, Kramer GW, Noordijk EM, et al. Cost-utility analysis of shortversus long-course palliative radiotherapy in patients with non-small cell lung cancer. J Natl Cancer Inst 2006; 98:1786-94. (Pubitemid 46017930)
51. Tang JI, Shakespeare TP, Lu JJ, et al. Patients' preference for radiotherapy fractionation schedule in the palliation of symptomatic unresectable lung cancer. J Med Imaging Radiat Oncol 2008; 52:497-502.
52. Hayman JA, Abrahamse PH, Lakhani I, et al. Use of palliative radiotherapy among patients with metastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2007; 69:1001-7. (Pubitemid 47625852)
53. Chow E, Wu JS, Hoskin P, et al. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 2002; 64:275-80. (Pubitemid 35254020)